Excalibur Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.15M | Sell |
37,425
-519
| -1% | -$121K | 3.29% | 6 |
|
|
2025
Q4 | $7.85M | Sell |
37,944
-222
| -0.6% | -$43.9K | 2.83% | 6 |
|
|
2025
Q3 | $7.08M | Sell |
38,166
-67
| -0.2% | -$11.5K | 2.57% | 6 |
|
|
2025
Q2 | $5.84M | Sell |
38,233
-555
| -1% | -$85.3K | 2.19% | 7 |
|
|
2025
Q1 | $6.43M | Sell |
38,788
-184
| -0.5% | -$28.8K | 2.53% | 6 |
|
|
2024
Q4 | $5.64M | Sell |
38,972
-721
| -2% | -$112K | 2.24% | 6 |
|
|
2024
Q3 | $6.43M | Sell |
39,693
-821
| -2% | -$131K | 2.45% | 6 |
|
|
2024
Q2 | $5.92M | Buy |
40,514
+629
| +2% | +$93.5K | 2.42% | 7 |
|
|
2024
Q1 | $6.31M | Buy |
39,885
+685
| +2% | +$109K | 2.67% | 7 |
|
|
2023
Q4 | $6.14M | Buy |
39,200
+376
| +1% | +$57.7K | 2.89% | 5 |
|
|
2023
Q3 | $6.05M | Buy |
38,824
+114
| +0.3% | +$18.8K | 3.14% | 5 |
|
|
2023
Q2 | $6.41M | Sell |
38,710
-12
| -0% | -$1.94K | 3.26% | 5 |
|
|
2023
Q1 | $6M | Sell |
38,722
-16
| -0% | -$2.58K | 3.11% | 6 |
|
|
2022
Q4 | $6.84M | Sell |
38,738
-400
| -1% | -$69.1K | 3.58% | 5 |
|
|
2022
Q3 | $6.39M | Buy |
39,138
+270
| +0.7% | +$45.7K | 3.58% | 5 |
|
|
2022
Q2 | $6.9M | Sell |
38,868
-1,344
| -3% | -$239K | 3.59% | 5 |
|
|
2022
Q1 | $7.13M | Buy |
40,212
+113
| +0.3% | +$19.2K | 3.09% | 6 |
|
|
2021
Q4 | $6.86M | Buy |
40,099
+835
| +2% | +$137K | 2.77% | 7 |
|
|
2021
Q3 | $6.34M | Sell |
39,264
-40
| -0.1% | -$6.82K | 2.78% | 9 |
|
|
2021
Q2 | $6.47M | Sell |
39,304
-1,759
| -4% | -$291K | 2.93% | 8 |
|
|
2021
Q1 | $6.75M | Buy |
41,063
+282
| +0.7% | +$45.6K | 3.33% | 5 |
|
|
2020
Q4 | $6.42M | Sell |
40,781
-1,172
| -3% | -$173K | 3.45% | 5 |
|
|
2020
Q3 | $6.25M | Sell |
41,953
-1,334
| -3% | -$197K | 3.79% | 6 |
|
|
2020
Q2 | $6.09M | Sell |
43,287
-542
| -1% | -$79K | 4.05% | 6 |
|
|
2020
Q1 | $5.75M | Buy |
43,829
+1,220
| +3% | +$173K | 4.43% | 5 |
|
|
2019
Q4 | $6.21M | Buy |
42,609
+6,372
| +18% | +$864K | 4.06% | 6 |
|
|
2019
Q3 | $4.69M | Sell |
36,237
-999
| -3% | -$132K | 4.21% | 8 |
|
|
2019
Q2 | $5.19M | Sell |
37,236
-660
| -2% | -$91.4K | 4.78% | 6 |
|
|
2019
Q1 | $5.3M | Sell |
37,896
-672
| -2% | -$90K | 5% | 5 |
|
|
2018
Q4 | $4.98M | Sell |
38,568
-4,763
| -11% | -$664K | 5.03% | 6 |
|
|
2018
Q3 | $5.99M | Sell |
43,331
-6,010
| -12% | -$799K | 5.11% | 5 |
|
|
2018
Q2 | $5.99M | Buy |
49,341
+14
| +0% | +$1.75K | 4.77% | 5 |
|
|
2018
Q1 | $6.32M | Sell |
49,327
-515
| -1% | -$69.6K | 5.14% | 4 |
|
|
2017
Q4 | $6.96M | Sell |
49,842
-1,267
| -2% | -$176K | 5.85% | 4 |
|
|
2017
Q3 | $6.64M | Buy |
51,109
+670
| +1% | +$88.8K | 5.65% | 4 |
|
|
2017
Q2 | $6.67M | Sell |
50,439
-2,565
| -5% | -$327K | 5.98% | 3 |
|
|
2017
Q1 | $6.6M | Buy |
53,004
+145
| +0.3% | +$17.3K | 5.88% | 3 |
|
|
2016
Q4 | $6.09M | Sell |
52,859
-145
| -0.3% | -$16.7K | 5.55% | 4 |
|
|
2016
Q3 | $6.26M | Sell |
53,004
-13,768
| -21% | -$1.67M | 5.94% | 4 |
|
|
2016
Q2 | $8.1M | Sell |
66,772
-325
| -0.5% | -$36.9K | 6.96% | 3 |
|
|
2016
Q1 | $7.26M | Sell |
67,097
-70
| -0.1% | -$7.25K | 6.5% | 4 |
|
|
2015
Q4 | $6.9M | Sell |
67,167
-691
| -1% | -$69.5K | 6.42% | 4 |
|
|
2015
Q3 | $6.33M | Buy |
67,858
+75
| +0.1% | +$7.25K | 6.34% | 4 |
|
|
2015
Q2 | $6.61M | Buy |
67,783
+1,904
| +3% | +$191K | 6.18% | 4 |
|
|
2015
Q1 | $6.63M | Buy |
65,879
+1,585
| +2% | +$161K | 6.41% | 4 |
|
|
2014
Q4 | $6.72M | Sell |
64,294
-2,079
| -3% | -$219K | 6.78% | 4 |
|
|
2014
Q3 | $7.08M | Sell |
66,373
-175
| -0.3% | -$18.1K | 7.27% | 4 |
|
|
2014
Q2 | $6.96M | Buy |
66,548
+605
| +0.9% | +$61.1K | 7.27% | 4 |
|
|
2014
Q1 | $6.48M | Buy |
65,943
+205
| +0.3% | +$19K | 7.1% | 4 |
|
|
2013
Q4 | $6.02M | Sell |
65,738
-2,235
| -3% | -$206K | 6.57% | 4 |
|
|
2013
Q3 | $5.89M | Buy |
67,973
+330
| +0.5% | +$29.6K | 6.92% | 4 |
|
|
2013
Q2 | $5.81M | Buy |
+67,643
| New | +$5.74M | 7.21% | 4 |
|
Other funds holding JNJ
VCM
VPM
Excalibur Management's JNJ Position: Q1 2026 in Review
Excalibur Management reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, selling an estimated $121K and leaving 37,425 shares worth $9.15M. The position accounts for 3.29% of the portfolio, ranked #6.
Excalibur Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Excalibur Management held 37,425 shares of Johnson & Johnson worth $9.15M as of Q1 2026.
- Excalibur Management sold 519 Johnson & Johnson shares in Q1 2026, an estimated $121K.
- Johnson & Johnson made up 3.29% of Excalibur Management's portfolio in Q1 2026, its #6 holding.
- Excalibur Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.